In the present study, we identified a novel lncRNA, POU6F2-AS1, whose expression is significantly upregulated in CRC; this upregulation phenotype is positively associated with poor clinical outcomes in CRC patients. The gene discussed is POU6F2; the disease is colorectal carcinoma.